0T6G.L
Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. Its lead product candidate is ADX-097, a humanized anti-C3d monoclonal antibody fusion protein to restore complement regulation, which has completed Phase I clinical trial for the treatment of renal and other complement-mediated diseases of high unmet need, including lupus nephritis, immunoglobulin A nephropathy, complement component 3 glomerulopathy, and anti-neutrophil cytoplasmic antibody-associated vasculitis. The company is also developing Bempikibart (A...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-10-04
Stock Exchange
LSE
Ticker
0T6G.L
According to Q32 Bio Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -67.71. This represents a change of 10.76% compared to the average of -0.62 of the last 4 quarters.
The mean historical PE Ratio of Q32 Bio Inc. over the last ten years is -15.84. The current -67.71 PE Ratio has changed 42.64% with respect to the historical average. Over the past ten years (40 quarters), 0T6G.L's PE Ratio was at its highest in in the March 2024 quarter at 52.23. The PE Ratio was at its lowest in in the March 2021 quarter at -110.42.
Average
-15.84
Median
-5.36
Minimum
-86.80
Maximum
-0.66
Discovering the peaks and valleys of Q32 Bio Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 34.17%
Maximum Annual PE Ratio = -0.66
Minimum Annual Increase = -73.17%
Minimum Annual PE Ratio = -86.80
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.88 | 34.17% |
| 2023 | -0.66 | -61.22% |
| 2022 | -1.69 | -68.46% |
| 2021 | -5.36 | 33.01% |
| 2020 | -4.03 | -51.99% |
| 2019 | -8.39 | -26.96% |
| 2018 | -11.49 | -50.68% |
| 2017 | -23.29 | -73.17% |
The current PE Ratio of Q32 Bio Inc. (0T6G.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.07
5-year avg
-2.52
10-year avg
-15.84
Q32 Bio Inc.’s PE Ratio is less than FibroGen, Inc. (-16.47), less than Lite Strategy, Inc. (-7.82), less than Adicet Bio, Inc. (-0.41), less than Sorrento Therapeutics, Inc. (-0.00), less than Affimed N.V. (-0.08), less than KALA BIO, Inc. (-0.18), less than Atara Biotherapeutics, Inc. (30.16), less than Insight Molecular Diagnostics Inc. (-0.03), less than Corbus Pharmaceuticals Holdings, Inc. (-2.16), less than Aclaris Therapeutics, Inc. (-2.66),
| Company | PE Ratio | Market cap |
|---|---|---|
| -16.47 | N/A | |
| -7.82 | N/A | |
| -0.41 | N/A | |
| -0.00 | N/A | |
| -0.08 | N/A | |
| -0.18 | N/A | |
| 30.16 | N/A | |
| -0.03 | N/A | |
| -2.16 | N/A | |
| -2.66 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Q32 Bio Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Q32 Bio Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Q32 Bio Inc.'s PE Ratio?
How is the PE Ratio calculated for Q32 Bio Inc. (0T6G.L)?
What is the highest PE Ratio for Q32 Bio Inc. (0T6G.L)?
What is the 3-year average PE Ratio for Q32 Bio Inc. (0T6G.L)?
What is the 5-year average PE Ratio for Q32 Bio Inc. (0T6G.L)?
How does the current PE Ratio for Q32 Bio Inc. (0T6G.L) compare to its historical average?